Tag | Content |
---|
EnhancerAtlas ID | HS093-28874 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr7:101929340-101930520 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
KLF16 | MA0741.1 | chr7:101930020-101930031 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930056-101930067 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930081-101930092 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930111-101930122 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101929568-101929579 | GGGGGCGTGGT | - | 6.14 | KLF5 | MA0599.1 | chr7:101930021-101930031 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930057-101930067 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930082-101930092 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930112-101930122 | GGGGCGGGGC | - | 6.02 | NHLH1 | MA0048.2 | chr7:101929959-101929969 | CGCAGCTGCG | + | 6.02 | NHLH1 | MA0048.2 | chr7:101930365-101930375 | CGCAGCTGCG | + | 6.02 | NHLH1 | MA0048.2 | chr7:101929959-101929969 | CGCAGCTGCG | - | 6.02 | NHLH1 | MA0048.2 | chr7:101930365-101930375 | CGCAGCTGCG | - | 6.02 | SP1 | MA0079.4 | chr7:101930019-101930034 | CGGGGGCGGGGCCTG | - | 6.11 | SP1 | MA0079.4 | chr7:101930055-101930070 | AGGGGGCGGGGCCAG | - | 6.57 | SP2 | MA0516.2 | chr7:101930054-101930071 | GAGGGGGCGGGGCCAGG | - | 6.09 | SP3 | MA0746.2 | chr7:101930080-101930093 | GGGGGGCGGGGCC | - | 6.11 | SP3 | MA0746.2 | chr7:101929567-101929580 | AGGGGGCGTGGTG | - | 6.29 | SP4 | MA0685.1 | chr7:101930053-101930070 | GGAGGGGGCGGGGCCAG | - | 7.25 | SP8 | MA0747.1 | chr7:101929567-101929579 | AGGGGGCGTGGT | - | 6.52 | Zfx | MA0146.2 | chr7:101930020-101930034 | GGGGGCGGGGCCTG | + | 6.19 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_58693 | chr7:101922324-101974102 | Ly1 | SE_60412 | chr7:101921972-101976670 | DHL6 | SE_61924 | chr7:101916815-101972690 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr7 | 101929978 | 101930313 | chr7 | 101929501 | 101929660 |
|
Enhancer Sequence | CAGCCCCACT GGTCTCTGCC CTAAAGCAGG CGAGTTCTGG AGCCAGGCAG GGGTGAGGAA 60 GGTGCCAGGG TTGTGGCCCC TCATCGCCCC TCTATGATCT CTGACACCTC TCCGGGTGGC 120 ATCAGGCCCC CATCACAGCG AAGGCTGGGT GGTGGGGGCA CTGCGCTCAG GGGGGCCGTC 180 CCGCCCTGTG GCCCGGGGGC GATTTCCCGC ACCGGAGGGC TGCAGGGAGG GGGCGTGGTG 240 GCGCCCTCGA GATTTATGAG AACCAGGCGT CGACTTCCTC CGTTGCGACA TCCAGGCCTC 300 CTCCAGGCTC CCATTGTCCC TGCTGCGGAG AGTCTGGCCA CAGCGGCGGC TCCCGCGAAG 360 CACCCGTCAG CGAGGGGCGC TTCGAGGGCG TCCGCGTCCC ATACACCCGC CACGCAGGAC 420 ATTCCCCCGG CCCCACGCTC CGCGCTCCCG GGGCCACCAC CACCGCGGGC TCGAGGGGTG 480 GCCTCCACGA GGAGGAGTGG GAGTCCCGCG CCTGGCCTGG GGCCGGCTCG GCGACATGGG 540 GACCCCCGCC CAGATGGGGC GACTCGGAGC CGGCTCCTAA CCCCTCTCTC CGGGCCCCAG 600 GACCGGGCAG TCTCGGCACC GCAGCTGCGG GGAGCCAGCA AGCACCGGCC ACCGGCGCCG 660 CTCGGGCTCC GCGGATGGCC GGGGGCGGGG CCTGAGCGGC GCAAGTGGGG GCGGGAGGGG 720 GCGGGGCCAG GACGCGCGAG GGGGGGCGGG GCCGGGGCTC GCGGCGGGGG CGGGGGCGGG 780 GCCGGGGCCG GGAGGCGCGC GCCTCGCGGG CGGGGGGCGC GCCGCGCTGG GCTGGGCTTG 840 GAGCGCGCGG AGCTCGGCTG CCAGAGAGCC GCGCGGGGGA CGCGCCGGGA CCGCGAGGAG 900 CGCAGGAGCC TTCGAGGCGG TGAACGAGGG AGGGAGCCCA GTCCGCCGCG GGCCATGAGC 960 CACCGGGCCC GGGGAGCCCG GCCGCGGTCC GGGCAGCGCT CAGCCGGCGC CCCAGCCCGC 1020 TCGGCCGCAG CTGCGCGCCT GTAGGTATGG CCTCCTTATA CCCAGTTCCT CGCTCCCTGG 1080 TCCTTCCCCC GGGACCCCTG TCTGTCCCCG GGGACGTGCG CTGTGTGCGC ACCGCTGCCC 1140 GAAGGAGAGC GGCCGCACGC GCCTTGGTCC GCGCGTGTCG 1180
|